Ashley Ingles, PhD

Senior Analyst

Dr. Ingles joined inThought in 2021 where she supports competitive decision making across several indications spanning oncology and infectious diseases. Prior to joining inThought, Dr. Ingles conducted postdoctoral research in genetic mechanisms of antibiotic resistance after completing her PhD in Microbiology and Molecular Genetics at Emory University as an NIH Ruth L. Kirschstein Predoctoral Fellow.

While at Emory, Dr. Ingles was a member of the Emory Biotech Consulting Club (EBCC) where she performed conference coverage and developed a market plan for technology being developed by an Emory investigator.